Hepatocellular Carcinoma

AASLD Hepatocellular Carcinoma

ASCO GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/76616

Contents of this Issue

Navigation

Page 4 of 7

Figure 2. The BCLC Staging System and Treatment Allocation HCC PS 0, Child-Pugh A Stage 0 PS 0-2, Child-Pugh A-B Stage A-C PS > 2 Child-Pugh C Stage D 1 HCC < 2 cm Very early stage (0) nodules < 3 cm PS 0 Early stage (A) 1 HCC or 3 Multinodular PS 0 Intermediate stage (B) Portal invasion N1, M1, PS 1-2 Advanced stage (C) stage (D) End 1 HCC Portal pressure/ bilirubin Increased Normal Associated diseases NO YES Resection Transplantation RFA Curative treatments TACE Sorafenib Palliative treatments 3 nodules ≤ 3 cm Symptomatic treatment

Articles in this issue

Archives of this issue

view archives of Hepatocellular Carcinoma - AASLD Hepatocellular Carcinoma